Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio
Saved in:
| Title: | Meridian Bioscience Achieves IVDR Certification for Alethia® Molecular Assay Portfolio |
|---|---|
| Authors: | Meridian Bioscience, Inc. |
| Source: | Business Wire (English). 02/24/2026. |
| Abstract: | Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced that a broad portfolio of its Alethia molecular assays has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. [ABSTRACT FROM PUBLISHER] |
| Database: | Regional Business News |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced that a broad portfolio of its Alethia molecular assays has successfully achieved CE marking under the European In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. [ABSTRACT FROM PUBLISHER] |
|---|
